Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) …

SA Amin, S Khatun, S Gayen, S Das, T Jha - European Journal of Medicinal …, 2023 - Elsevier
Abstract Histone deacetylase 8 (HDAC8) aberrantly deacetylates histone and non-histone
proteins. These include structural maintenance of chromosome 3 (SMC3) cohesin protein …

Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability

V Gaggioli, CSY Lo, N Reverón-Gómez… - Nature cell …, 2023 - nature.com
Chromatin is dynamically reorganized when DNA replication forks are challenged. However,
the process of epigenetic reorganization and its implication for fork stability is poorly …

[HTML][HTML] BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection

Y Chen, X Yi, B Huo, Y He, X Guo, Z Zhang… - Pharmacological …, 2022 - Elsevier
Smooth muscle cell (SMC) loss is the characteristic feature in the pathogenesis of aortic
dissection (AD), and ferroptosis is a novel iron-dependent regulated cell death driven by the …

Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

Y Gao, H Zhang, F Lirussi, C Garrido, XY Ye… - Biochemical …, 2020 - Elsevier
Epigenetic enzymes histone deacetylases (HDACs) are clinically validated anticancer drug
targets which have been studied intensively in the past few decades. Although several drugs …

Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: current progress and novel strategies

D Li, X Peng, Z Hu, S Li, J Chen, W Pan - European journal of medicinal …, 2023 - Elsevier
Histone methyltransferases (HMTs) play a critical role in gene post-translational regulation
and diverse physiological processes, and are implicated in a plethora of human diseases …

A review of advanced cutaneous melanoma therapies and their mechanisms, from immunotherapies to lysine histone methyl transferase inhibitors

RS de Oliveira Filho, DA de Oliveira, MM Nisimoto… - Cancers, 2023 - mdpi.com
Simple Summary Advanced cutaneous melanoma is the most aggressive type of skin cancer
and has variable rates of treatment response. Currently, there are some classes of …

[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …

[HTML][HTML] Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs

Q Liao, J Yang, S Ge, P Chai, J Fan, R Jia - Journal of Pharmaceutical …, 2023 - Elsevier
The reversible and precise temporal and spatial regulation of histone lysine
methyltransferases (KMTs) is essential for epigenome homeostasis. The dysregulation of …

Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment

E Shirbhate, V Singh, V Jahoriya, A Mishra… - European journal of …, 2023 - Elsevier
A significant advancement in the field of epigenetic drug discovery has been evidenced in
recent years. Epigenetic alterations are hereditary, nevertheless reversible variations to …